PIM
PALI icon

Platinum Investment Management’s Palisade Bio PALI Stock Holding History

Platinum Investment Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Buy
1,730,866
+499,452
+41% +$983K 0.89% 39
2026
Q1 		$2.15M Buy
1,231,414
+567,327
+85% +$1.03M 0.54% 60
2025
Q4 		$1.56M Buy
+664,087
New +$1.28M 0.36% 73

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Platinum Investment Management's PALI Position: Q2 2026 in Review

Platinum Investment Management increased its Palisade Bio (PALI) stake by 41% in Q2 2026, buying an estimated $983K and bringing the position to 1,730,866 shares worth $3.62M. The position accounts for 0.89% of the portfolio, ranked #39.

Platinum Investment Management first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Platinum Investment Management held 1,730,866 shares of Palisade Bio worth $3.62M as of Q2 2026.
  • Platinum Investment Management bought 499,452 Palisade Bio shares in Q2 2026, an estimated $983K.
  • Palisade Bio made up 0.89% of Platinum Investment Management's portfolio in Q2 2026, its #39 holding.
  • Platinum Investment Management first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Platinum Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.